2008

April - SciTech has been chosen by the National Institutes of Health Commercialization Assistance Program (NIH-CAP) to present at the Larta Institute's 2008 Venture Forum, the largest and longest running showcase of early stage innovation and entrepreneurship. On 30 CAP companies were selected to participate in the forum on May 30th (www.theventureforum.com).

"SciTech has a promising anticancer drug," said NIH-CAP Principal Advisor Louis Scarmoutzos, a member of the NIH committee that selected SciTech to participate in the Larta forum. "It shows a great deal of probability of being successful, which is no small feat. There's a vast minefield of drug candidates that have failed. One of the unique features of SciTech's drug is that it has been used in good model systems that include human data. SciTech actually has the right mix of science and business acumen."

To read more go to: http://www.media.wayne.edu/2008/05/02/techtowns-scitech-honored-by-nih-michigan-growth

SciTech was selected to present at the 2008 Michigan Growth Capital Symposium, where investors meet the "Best of the Midwest" in emerging technologies, on May 14th and 15th.

February - SciTech competed in Washington, DC to present at the Larta Institute's 2008 Venture Forum in San Clara California.

SciTech Board of Advisors meeting validates the extensive potential.

2007

September - SciTech was selected to participate in the 2007-2008 HIH SBIR Commercialization Assistance Program (CAP), a customized and individualized commercial market-based program for SBIR Phase II grantees.

August - SciTech submits SBIR grant application entitled "The Prophylactic Effects of the Calcium Ionophores on Wound Healing in Diabetic and Senescent Skin".

SciTech Development listed in Crain’s Detroit Business 2007 Book of Lists and Detroit Yearbook: University Research